Sign In
Buy STE
$228.40
-2.81 (-1.22%)
At Close: Jul 31, 2026
Steris: May Benefit From Bringing Pharmaceutical Manufacturing Back To The U.S.
04:27pm, Thursday, 15'th May 2025
Steris plc remains a Strong Buy with a fair value of $281, supported by robust organic growth and margin expansion. The Trump administration's push to reshore pharma manufacturing could be a major tai
STERIS plc (STE) Q4 2025 Earnings Call Transcript
01:52pm, Thursday, 15'th May 2025
STERIS plc (NYSE:STE ) Q4 2025 Results Conference Call May 15, 2025 9:00 AM ET Company Participants Julie Winter - Investor Relations Mike Tokich - Senior Vice President and Chief Financial Officer Da
STE Q4 Earnings Beat, Margins Expand, Stock Up in Aftermarket
09:41am, Thursday, 15'th May 2025
STERIS' fourth-quarter fiscal 2025 results reflect strong growth momentum in Healthcare and AST revenues.
Here's What Key Metrics Tell Us About Steris (STE) Q4 Earnings
07:30pm, Wednesday, 14'th May 2025
Although the revenue and EPS for Steris (STE) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street es
Steris (STE) Surpasses Q4 Earnings Estimates
06:45pm, Wednesday, 14'th May 2025
Steris (STE) came out with quarterly earnings of $2.74 per share, beating the Zacks Consensus Estimate of $2.59 per share. This compares to earnings of $2.41 per share a year ago.
Steris forecasts annual profit above estimates on strong medical equipment sales
05:26pm, Wednesday, 14'th May 2025
Medical equipment maker Steris forecast annual profit above analysts' estimate on Wednesday, banking on strength in its biggest segment that sells sterilization products, sending its shares up more th
Steris Fiscal Fourth-Quarter 2025 Financial Results: Just the Numbers
05:06pm, Wednesday, 14'th May 2025
Medical equipment maker Steris (STE) on Wednesday afternoon reported fiscal fourth-quarter 2025 financial results. A summary of its key numbers is below.
STERIS Announces Financial Results for Fiscal 2025 Fourth Quarter and Full Year
04:30pm, Wednesday, 14'th May 2025
DUBLIN, IRELAND, May 14, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2025 fourth quarter and full year ended Ma
What Analyst Projections for Key Metrics Reveal About Steris (STE) Q4 Earnings
10:20am, Friday, 09'th May 2025
Get a deeper insight into the potential performance of Steris (STE) for the quarter ended March 2025 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some o
STERIS Declares Dividend of $0.57 per share
04:30pm, Wednesday, 07'th May 2025
DUBLIN, IRELAND, May 07, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly interim dividend of $0.57 per
10 Undervalued Dividend Growth Stocks: May 2025
09:00am, Wednesday, 07'th May 2025
I rank a selection of undervalued dividend growth stocks in Dividend Radar and present the top ten stocks for consideration. I use two valuation screens, one based on my fair value estimate, and anoth
Will Applied Sterilization Growth Help STE Beat Q4 Earnings Estimates?
02:10pm, Tuesday, 06'th May 2025
STERIS is expected to have experienced an increase in bioprocessing demand in the fourth quarter.
STERIS to Host a Conference Call for Fiscal 2025 Fourth Quarter and Full Year Financial Results on May 15, 2025
04:30pm, Tuesday, 22'nd Apr 2025
DUBLIN, IRELAND, April 22, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2025 fourth qua
Is it the Right Time to Hold STERIS Stock in Your Portfolio?
11:25am, Wednesday, 16'th Apr 2025
STE stays on investors' radars due to the strength of its Healthcare arm and strong rebound potential in the AST segment.
Steris: AST Recovery Is Ongoing; Upgrading To 'Strong Buy'
07:22am, Saturday, 22'nd Mar 2025
Upgraded Steris to 'strong buy' with a fair value of $254 per share due to strong recovery in its Applied Sterilization Technologies (AST) business. AST segment showed 9.5% organic growth, with manage
